SRF–YAP–IL6 signalling is enriched in MaSC/progenitor cell-like basal-like breast cancer (BLBC) in patients' samples and is required for generation of cancer stem cells (CSCs) and cancer relapse specifically in BLBC. The gene discussed is IL6; the disease is cancer.